Caister Academic Press

Cytomegaloviruses: From Molecular Pathogenesis to Intervention (Vol. 2) | Book

"intended for a wide audience" Ref. Res. Book News
Publisher: Caister Academic Press
Edited by: Matthias J. Reddehase
Institute for Virology, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany
Pages: xxviii + 540
Hardback:
Publication date: April 2013Add to cart
ISBN: 978-1-908230-20-1
Price: GB £219 or US $399
Supplementary material

See also: Volume 1

Human Cytomegalovirus (CMV), a member of the herpesvirus family, is an under-rated health risk. Low public awareness results from the relatively mild symptoms it causes in otherwise healthy people whose immune system is intact, with primary infection thus usually going unnoticed. During pregnancy, however, transmission from the mother to the fetus is currently the most frequent viral cause of birth defects with life-long neurological sequelae, sensorineural hearing loss in particular. People at risk also include the growing number of immunocompromised patients requiring either a solid organ graft or receiving a hematopoietic cell graft for the treatment of hematopoietic malignancies that are refractory to standard therapies. Under the condition of weakened immune surveillance in these patients, latent CMV hidden in transplanted donor cells or in the recipients' own tissues can awake to cause a destructive infection resulting in graft loss and multiple end-organ disease, of which viral pneumonia is the most feared.

Volume 2 of a two-volume work that is an updated and upgraded 2nd-edition of 'Cytomegaloviruses: Molecular Biology and Immunology' (2006). The title 'Cytomegaloviruses: From Molecular Pathogenesis to Intervention' reflects its expanded commitment not only to cover cutting-edge basic science but also to include the translation of this to clinical science. In an interdisciplinary approach to understanding CMV disease and outlining options for prevention and treatment, leading international experts provide comprehensive and authoritative reviews on literally every aspect of current research with an unprecedented completeness, integrating research on human CMV and insights gained from experimental animal models. Volume II is more clinically-oriented, covering the immune response to CMV, the most pressing medical problems in the newborn and in transplantation patients, as well as diagnostics, the management of antiviral drug resistance, the state and future of a CMV vaccine, and the potential of using CMV as a vaccine vector to fight unrelated diseases. The book closes with a critical survey of disputed associations between CMV and atherosclerotic cardiovascular disease, certain tumors such as Glioblastoma Multiforme, and the phenomenon of 'immune senescence' in the elderly.

The book is liberally illustrated with figures, most of which are in full colour. There are many tables and plentiful references which enhance the book even further making it an invaluable source of information. Essential reading for all virologists with an interest in cytomegaloviruses, for all clinicians in pediatric intensive-care medicine and at transplantation centers, for scientists working on antiviral drug and vaccine development, as well as for public health service and science funding system authorities.

Reviews

"intended for a wide audience of virologists, clinicians in intensive care medicine and transplantation centres, researchers involved with antiviral drug and vaccine development, and public health and science funding authorities" from Ref. Res. Book News (June 2013).

Table of contents
II.1. Synopsis of Clinical Aspects of Human Cytomegalovirus Disease
Suresh B. Boppana and William J. Britt
II.2. The Epidemiology and Public Health Impact of Congenital Cytomegalovirus Infection
Michael J. Cannon, Scott D. Grosse and Karen B. Fowler
II.2- Addendum. The Economic Impact of Congenital CMV Infection: Methods and Estimates
Scott D. Grosse, Ismael R. Ortega-Sanchez, Stephanie R. Bialek and Sheila C. Dollard
II.3. Clinical Cytomegalovirus Research: Congenital Infection
Stuart P. Adler and Giovanni Nigro
II.4. Cytomegalovirus Replication in the Developing Human Placenta
Lenore Pereira, Takako Tabata, Matthew Petitt and June Fang-Hoover
II.5. The Guinea Pig Model of Congenital Cytomegalovirus Infection
Alistair McGregor, Michael A. McVoy and Mark R. Schleiss
II.6. Murine Model of Neonatal Cytomegalovirus Infection
William J. Britt, Djurdjica Cekinović and Stipan Jonjić
II.7. Adaptive Cellular Immunity to Human Cytomegalovirus
Mark R. Wills, Gavin M. Mason and J. G. Patrick Sissons
II.8. Natural Killer Cells and Human Cytomegalovirus
Gavin W. G. Wilkinson, Rebecca J. Aicheler and Eddie C. Y. Wang
II.9. Innate Immunity to Cytomegalovirus in the Murine Model
Silvia Vidal, Astrid Krmpotić, Michal Pyzik and Stipan Jonjić
II.10. Protective Humoral Immunity
Michael Mach, Anna-Katharina Wiegers, Nadja Spindler and Thomas Winkler
II.11. Immunoregulatory Cytokine Networks Discovered and Characterized during Murine Cytomegalovirus Infections
Marc Dalod and Christine A. Biron
II.12. Host Genetic Models in Cytomegalovirus Immunology
Chris A. Benedict, Karine Crozat, Mariapia Degli-Esposti and Marc Dalod
II.13. Clinical Cytomegalovirus Research: Thoracic Organ Transplantation
Robin K. Avery
II.14. Clinical Cytomegalovirus Research: Liver and Kidney Transplantation
Vincent C. Emery, Richard S.B. Milne and Paul D. Griffiths
II.15. The Rat Model of Cytomegalovirus Infection and Vascular Disease
Sebastian Voigt, Jakob Ettinger and Daniel N. Streblow
II.16. Clinical Cytomegalovirus Research: Hematopoietic Cell Transplantation
Sachiko Seo and Michael Boeckh
II.17. Murine Model for Cytoimmunotherapy of CMV Disease after Hematopoietic Cell Transplantation
Rafaela Holtappels, Stefan Ebert, Jürgen Podlech, Annette Fink, Verena Böhm, Niels A.W. Lemmermann, Kirsten Freitag, Angélique Renzaho, Doris Thomas and Matthias J. Reddehase
II.18. State of the Art and Trends in Cytomegalovirus Diagnostics
Maria Grazia Revello and Giuseppe Gerna
II.19. Antiviral Therapy, Drug Resistance, and Computed Resistance Profiling
Detlef Michel, Meike Chevillotte and Thomas Mertens
II.20. Cytomegalovirus Vaccine: On the Way to the Future?
Stanley A. Plotkin and Bodo Plachter
II.21. Vaccine Vectors Using the Unique Biology and Immunology of Cytomegalovirus
Michael A. Jarvis, Scott G. Hansen, Jay A. Nelson, Louis J. Picker and Klaus Früh
II.22. Non-Human-Primate Models of Cytomegalovirus Infection, Prevention, and Therapy
Klaus Früh, Daniel Malouli, Kristie L. Oxford and Peter A. Barry
II.23. Putative Disease Associations with Cytomegalovirus: a Critical Survey
Ann B. Hill
II.24. Résumé and Visions: From CMV Today to CMV Tomorrow
Ulrich H. Koszinowski

How to buy this book

(EAN: 9781908230201 Subjects: [microbiology] [virology] [medical microbiology] [genomics] )